ACUTE MYELOID LEUKEMIA
What causes a blood
cancer like AML?
Changes in a blood-forming cell can disrupt how it matures, grows and survives. Its abnormal descendants can interfere with healthy blood production.
Blood begins here.
Your marrow contains stem and progenitor cells that produce blood through several stages of development.
The nucleus contains DNA. AML begins in the blood-forming system, not when a mature red blood cell turns cancerous.
What am I looking at?+
The outer membrane encloses cytoplasm. Inside the nucleus, DNA is packaged with proteins as chromatin. It is not usually a collection of distinct X-shaped chromosomes.
Mature red blood cells have no nucleus. Neutrophils have a lobed nucleus. Platelets are small fragments released by megakaryocytes, not miniature white blood cells.
The diagram selects a few blood lineages. It omits many intermediate stages and other cells, including lymphocytes. It does not show a myeloblast turning into all three outputs.
Zoom into the instructions.
Start with a blood-forming cell. Each click takes you closer to its DNA.
- Cell
- Nucleus
- Chromatin
- DNA
A changed letter is not a diagnosis. This invented segment is not a specific AML mutation or the BCL2 gene.
One survival mechanism in an AML cell.
Normal cells use BCL-2 too. AML cells can depend on different survival proteins. This example is separate from the invented DNA substitution.
Purple cells + diamond = abnormal clone in the diagrams.
How can a DNA change affect a cell?+
A change can alter a protein or how much of it is made. Other changes alter gene regulation. Effects depend on the gene, the exact change and the cell’s other changes; many DNA variants are harmless.
Epigenetic changes can alter how genes are used without changing the DNA letters. AML biology involves gene regulation as well as sequence changes.
Most AML-associated changes are acquired during life. Some people inherit a predisposition. “Genetic” does not automatically mean “inherited.”
One real AML example: a gene fusion+
In one subtype, a rearrangement between chromosomes 8 and 21 joins parts of RUNX1 and RUNX1T1.
The fusion protein disrupts a gene-regulating complex and blood-cell maturation. Additional changes usually cooperate in producing leukemia. This is one example, not the explanation for every AML.
The changes can be passed on.
In AML, cooperating abnormalities can give a cell lineage an advantage. Its abnormal descendants accumulate.
Does an expanding clone always mean AML?+
No. A mutation-bearing blood-cell clone can exist without leukemia. Clonal hematopoiesis of indeterminate potential (CHIP) is one such setting.
There is no universal “two mutations = AML” rule. AML includes biologically different diseases. Diagnosis combines blood and marrow findings with genetic and other laboratory tests.
This lineage shows shared ancestry. An additional change can distinguish one branch from the others. It does not necessarily make that branch more aggressive. New changes do not occur on a fixed division schedule.
Too little of what blood needs.
Leukemia disrupts the marrow’s ability to supply functional blood cells.
Red cells → oxygenToo few can cause anemia and fatigue.
Functional white cells → defenseToo few or poorly functioning cells raise infection risk.
Platelets → clottingToo few can cause bruising and bleeding.
Why did the changes happen?+
Often, the cause in an individual is unknown. Changes can arise during cell division; exposures and inherited predispositions can also contribute.
Risk factors include older age, smoking, benzene, certain prior cancer treatments, some blood disorders and some inherited conditions. A risk factor is not proof of why one person developed AML.
This lesson explains disease biology, not the cause or genetic findings of Dave’s illness.
A high white count can be misleading+
The total white blood cell count in AML may be high, normal or low. More circulating leukemia cells do not mean stronger infection defense.
Reduced normal production is not just a space problem: abnormal cells and their interactions with the marrow environment disrupt healthy hematopoiesis. Cell counts, symptoms and AML subtype vary between patients.
Read more: blood counts in AML · experimental research on the marrow environment.
THE CONNECTION
Blood cancer changes a system that normally renews itself. The next lesson explores how treatment controls leukemia and how a transplant can rebuild blood formation.